A single-dose PK study of onapristone including the effect of food on absorption.

Abstract

PURPOSE:

Onapristone is an antiprogestin with activity in breast cancer and is under investigation for use in endometrial, ovarian and prostate cancers. Megestrol acetate and abiraterone generally show variability in absorption and, depending on the formulation, food effect. This study was conducted to determine the effect of food on 10 mg oral immediate-release (IR) onapristone and to help identify a formulation to minimize variability.

METHODS:

This is an open-label, randomized, crossover study to determine the pharmacokinetic profile of onapristone and its main metabolite, N-mono-desmethyl onapristone. Twelve healthy female subjects received 10 mg of oral IR onapristone after an overnight fast, or within 30 min of a high-fat, high-calorie meal with a 2-week washout between dosing periods.

RESULTS:

Onapristone plasma t1/2 (mean ± SD) was 4.36 ± 0.81 h for the fasted state and 3.76 ± 0.36 h for the fed state. Following food, onapristone tmax was delayed from 1 to 4 h. Food intake was also associated with a small increase in AUC0-∞ of approximately 13 % and a statistically significant decrease in Cmax of approximately 18 %. One subject experienced a 23-day delay in menses after one 10 mg onapristone dose, while another subject experienced transient grade 2 NCI-CTCAE liver enzyme elevation 3 weeks post dose.

CONCLUSION:

The results are consistent with previous observations, indicating that there is a small increase in onapristone exposure and a significant decrease in Cmax when taken with food. These changes are within acceptable limits set out by the FDA. Thus, our findings indicate that onapristone could be administered without regard to food.

• Authors: Keyvan Rezai, Didier Chassard, Caroline Denot, Stefan Proniuk, Alexander Zukiwski, Erard Gilles, Haydeé L Ramos, Alain Patat, Alice Bexon, François Lokiec
• Journal: Cancer chemotherapy and pharmacology (Cancer Chemother Pharmacol) Vol. 76 Issue 1 Pg. 171-7 (Jul 2015) ISSN: 1432-0843 [Electronic] Germany
• PMID: 26006702 (Publication Type: Journal Article, Randomized Controlled Trial)

Chemical References

• Antineoplastic Agents
• Gonanes
• onapristone

Topics

• Adult
• Antineoplastic Agents (blood, pharmacokinetics)
• Cross-Over Studies
• Fasting (blood, metabolism)
• Female
• Food-Drug Interactions
• Gonanes (blood, pharmacokinetics)
• Humans
• Intestinal Absorption
• Molecular Structure
• Young Adult